NPI: 1639147259 · OCOEE, FL 34761 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/09/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/09/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,366 | $3.44M |
| 2019 | 17,308 | $3.21M |
| 2020 | 22,796 | $3.23M |
| 2021 | 14,834 | $1.24M |
| 2022 | 9,885 | $1.99M |
| 2023 | 2,523 | $309K |
| 2024 | 82 | $3K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 28,413 | 1,156 | $4.91M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,635 | 1,515 | $3.62M |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,282 | 935 | $2.54M |
| J1756 | Injection, iron sucrose, 1 mg | 4,246 | 672 | $584K |
| A4657 | Syringe, with or without needle, each | 2,502 | 1,236 | $507K |
| 85041 | 1,607 | 993 | $239K | |
| 85048 | 1,590 | 977 | $232K | |
| 83970 | 1,011 | 604 | $195K | |
| 83550 | 1,073 | 677 | $173K | |
| 83540 | 1,073 | 676 | $173K | |
| 82728 | 835 | 536 | $139K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 125 | 62 | $27K |
| 82607 | 126 | 90 | $21K | |
| 82746 | 123 | 86 | $21K | |
| 82108 | 127 | 90 | $21K | |
| G0008 | Administration of influenza virus vaccine | 13 | 13 | $3K |
| 90662 | 13 | 13 | $3K |